Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica
- Substances:Secukinumab
Denmark- Participants:18–64 years · 65+ years
- Substances:Secukinumab
- Sponsor:Novartis Pharma AG
Rare diseases
Investigational molecules
Locations
Back to Denmark184 clinical trials in Vejle, Denmark across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
Denmark
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on advanced treatments for various cancer types, particularly metastatic prostate cancer, chronic lymphocytic leukemia, and colorectal cancer. Studies are evaluating innovative therapies and treatment combinations.
Research emphasizes personalized treatment approaches and novel drug combinations to improve patient outcomes.
Investigations into treatments for chronic inflammatory conditions, including rhinosinusitis, psoriatic arthritis, and inflammatory bowel diseases. Studies are evaluating biologic therapies and their optimal usage.
Focus on developing targeted therapies and understanding treatment duration optimization.
Research into respiratory conditions, particularly focusing on severe asthma and viral lung infections. Studies are examining new therapeutic approaches and treatment effectiveness.
Emphasis on developing innovative treatments for patients with difficult-to-control respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.